I know it's still a while away, but 'InCann' has been mentioned a few times now:
'InCann is a bioactive Capsule for symptoms of Crohn's disease and Irritable Bowel Syndrome (IBS). Currently, the latest research and results are based on observational research in Israel and pre-clinical trials on humans in Europe. An official clinical trial program will be initiated in Q2 next year.'
Another big market to tap into. Here's to hoping.
Dementia, page-3
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.025(7.81%) |
Mkt cap ! $13.35M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 29.5¢ | $23 | 77 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 303 | 1 |
View Market Depth
| Last trade - 13.43pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
30.0¢ |
Change
-0.025 ( 7.69 %) |
||||
| Open | High | Low | Volume | ||
| 30.0¢ | 30.0¢ | 30.0¢ | 500 | ||
| Last updated 13.59pm 11/06/2024 ? | |||||
| RGT (ASX) Chart |